Stock Based Compensation (Tables)

9 Months Ended

Jun. 30, 2017

Schedule Of Stock Compensation Expense [Table Text Block]

Stock compensation expense for the three and nine months ended June 30, 2017 and 2016 is as follows:

	Three Months Ended		Three Months Ended
Stock Compensation Expense	June 30, 2017		June 30, 2016
Stock grants	$	60,000	$	74,000
Restricted stock grants		13,000		13,000
Option grants		12,000		12,000
Employee stock purchase plan		1,000		1,000
Subsidiary stock grants		-		210,000
Subsidiary option grants		30,000		19,000
Total	$	116,000	$	329,000

	Nine Months Ended		Nine Months Ended
Stock Compensation Expense	June 30, 2017		June 30, 2016
Stock grants	$	183,000	$	259,000
Restricted stock grants		39,000		33,000
Option grants		37,000		29,000
Employee stock purchase plan		2,000		2,000
Subsidiary stock grants		-		210,000
Subsidiary option grants		82,000		59,000
Total	$	343,000	$	592,000

Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]

A summary of restricted stock activity for the nine months ended June 30, 2017 is presented below:

Restricted Stock Activity for the Nine Months ended			Weighted-Average
June 30, 2017	Shares		Grant-Date Fair Value
Nonvested at September 30, 2016		100,000	$	1.73
Granted		-		-
Vested		(30,000)		1.73
Cancelled		-		-
Nonvested at June 30, 2017		70,000	$	1.73

Stock Option Grants [Member]

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]

The assumptions used in the Black-Scholes option pricing model for the stock option grant during the nine months ended June 30, 2017 were as follows:

	FY 2017
Expected term in years		3 years
Risk-free interest rate		1.48	%
Expected volatility		69.57	%
Expected dividend yield		0.00	%

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]

A summary of stock option activity for the nine months ended June 30, 2017 is presented below:

			Weighted Average		Weighted Average
	Options		Exercise Price per		Remain Contractual
	Outstanding		Share		Term (in Years)
Balance at September 30, 2016		123,147	$	2.30		1.69
Outstanding and exercisable at September 30, 2016		123,147		2.30		1.69
Granted		95,602		1.80		2.59
Exercised		-		-
Cancelled		(21,980)		3.03
Balance at June 30, 2017		196,769		1.98		1.89
Outstanding and exercisable at June 30, 2017		196,769	$	1.98		1.89

Subsidiary Option Grants [Member]

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]

These options were valued using the Black-Scholes option pricing model and the assumptions for that were as follows:

Expected term in years	10 years
Risk-free interest rate	2.42	%
Expected volatility	83.11	%
Expected dividend yield	0.00	%

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]

A summary of Xcede stock option activity for the nine months ended June 30, 2017 is presented below:

			Weighted Average		Weighted Average
	Options		Exercise Price per		Remain Contractual
	Outstanding		Share		Term (in Years)
Balance at September 30, 2016		613,653	$	1.00		8.35
Outstanding and exercisable at September 30, 2016		320,586		1.00		8.01
Granted		810,500		1.00
Exercised		-		-
Cancelled		(48,197)		1.00
Balance at June 30, 2017		1,375,956		1.00		8.96
Outstanding and exercisable at June 30, 2017		827,155	$	1.00		8.47